With the SARS-CoV-2 Inhibition by Hybrid Graphene Nanoplatelet/Metal Oxide Powders announcement, Share Talk spoke with CEO, Neill Ricketts.

Versarien Plc (AIM: VRS), the advanced materials engineering group, announced the receipt of an independent report (the "Report") produced by Ankara University, Turkey, detailing the results of a preliminary study of modified graphene materials provided by Versarien for use against SARS-CoV-2, the strain of coronavirus that causes coronavirus disease 2019, COVID-19.

The Report concludes that the preliminary test results show that these materials significantly inhibit viral infection and possess anti-viral activity towards SARS-CoV-2.

https://www.share-talk.com/neill-ricketts-ceo-of-versarien-plc-vrs-l-interview/